Lunasin does not slow ALS progression: results of an open-label, single-center, hybrid-virtual 12-month trial

.
Source: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration - Category: Neurology Authors: Source Type: research
More News: ALS | Neurology